can you gain weight on semaglutide Gain: Causes, Risks, and Prevention Strategies Weight Gain on Semaglutide: Causes

MT-II for multi-effect melanocortin research (tanning + libido + appetite)

In contrast, Chen et al

Home Medical news & Guidelines Anesthesiology Cardiology and CTVS Critical Care Dentistry Dermatology Diabetes and Endocrinology ENT Gastroenterology Medicine Nephrology Neurology Obstretics-Gynaecology Oncology Ophthalmology Orthopaedics Pediatrics-Neonatology Psychiatry Pulmonology Radiology Surgery Urology Laboratory Medicine Diet Nursing Paramedical Physiotherapy Health news Fact Check Bone Health Fact Check Brain Health Fact Check Cancer Related Fact Check Child Care Fact Check Dental and oral health fact check Diabetes and metabolic health fact check Diet and Nutrition Fact Check Eye and ENT Care Fact Check Fitness fact check Gut health fact check Heart health fact check Kidney health fact check Medical education fact check Men's health fact check Respiratory fact check Skin and hair care fact check Vaccine and Immunization fact check Women's health fact check AYUSH State News Andaman and Nicobar Islands Andhra Pradesh Arunachal Pradesh Assam Bihar Chandigarh Chattisgarh Dadra and Nagar Haveli Daman and Diu Delhi Goa Gujarat Haryana Himachal Pradesh Jammu & Kashmir Jharkhand Karnataka Kerala Ladakh Lakshadweep Madhya Pradesh Maharashtra Manipur Meghalaya Mizoram Nagaland Odisha Puducherry Punjab Rajasthan Sikkim Tamil Nadu Telangana Tripura Uttar Pradesh Uttrakhand West Bengal Medical Education Industry New Study Links GLP-1 Medications to Higher Testosterone and Better Sperm Count - Video Overview Men taking GLP-1 medications for weight loss or diabetes may gain an unexpected benefit beyond improved metabolic health-better fertility, according to new research presented at the Endocrine Society's ENDO 2026 meeting

Reconstitution: We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom

The risk of generalised skin reactions, such as widespread rash or urticaria, appears to be low based on current evidence, though trial populations may not fully reflect the diversity of patients who would use the medication in routine clinical practice

Understanding these risks is as important as documenting the benefits